rs752137335
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_001953.5(TYMP):āc.128A>Cā(p.Lys43Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 33)
Exomes š: 0.0000027 ( 0 hom. )
Consequence
TYMP
NM_001953.5 missense
NM_001953.5 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 1.04
Genes affected
TYMP (HGNC:3148): (thymidine phosphorylase) This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.966
PP5
Variant 22-50529582-T-G is Pathogenic according to our data. Variant chr22-50529582-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 223015.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYMP | NM_001953.5 | c.128A>C | p.Lys43Thr | missense_variant | 2/10 | ENST00000252029.8 | NP_001944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYMP | ENST00000252029.8 | c.128A>C | p.Lys43Thr | missense_variant | 2/10 | 1 | NM_001953.5 | ENSP00000252029.3 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152268Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152268
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248896Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135236
GnomAD3 exomes
AF:
AC:
3
AN:
248896
Hom.:
AF XY:
AC XY:
1
AN XY:
135236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460782Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726728
GnomAD4 exome
AF:
AC:
4
AN:
1460782
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
726728
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74392
GnomAD4 genome
AF:
AC:
5
AN:
152268
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 43 of the TYMP protein (p.Lys43Thr). This variant is present in population databases (rs752137335, gnomAD 0.02%). This missense change has been observed in individual(s) with TYMP-related conditions (PMID: 14720311). ClinVar contains an entry for this variant (Variation ID: 223015). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TYMP protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Mitochondrial DNA depletion syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | GeneReviews | Jan 14, 2016 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 30, 2023 | Variant summary: TYMP c.128A>C (p.Lys43Thr) results in a non-conservative amino acid change located in the N-terminal domain (IPR017459) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 248896 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.128A>C has been reported in the literature in an individual affected with Mitochondrial DNA Depletion Syndrome 1 (MNGIE type), who fulfilled the clinical criteria for the disease, and had undetectable thymidine phosphorylase (TP) activity with elevated plasma thymidine levels (Hirano_2004). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, a neighboring missense change (p.R44Q) has also been reported in affected individual(s) (HGMD), indicating a functional importance for this protein region. The following publications have been ascertained in the context of this evaluation (PMID: 14720311, 17549623, 19748572). Two submitters have provided clinical-significance assessments for this variant in ClinVar after 2014, and classified the variant as pathogenic / likely pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;D;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;H;H;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
D;.;D;D;.
Vest4
MutPred
Loss of ubiquitination at K43 (P = 0.0283);Loss of ubiquitination at K43 (P = 0.0283);Loss of ubiquitination at K43 (P = 0.0283);Loss of ubiquitination at K43 (P = 0.0283);Loss of ubiquitination at K43 (P = 0.0283);
MVP
MPC
1.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at